Dr. Ross L. Prentice

powered by
COS Expertise®
Fred Hutchinson Cancer Research Center
Public Health Sciences
Full Member
University of Washington
School of Public Health and Community Medicine
Biostatistics
Professor
Professional Headshot of Ross L. Prentice

Mailing Address

1100 Fairview Avenue N
P.O. Box 19024
M3-A410
Seattle, Washington 98109-1024
United States

Contact Information

Phone: (206) 667-4264
Fax: (206) 667-4142
rprentic@whi.org

Qualifications

Ph.D., University of Toronto, Statistics, 1970.
M.Sc., University of Toronto, Statistics, 1968.
B.Sc., University of Waterloo, Mathematics, 1967.

Expertise and Research Interests

My statistical methods research, in conjunction with colleagues and students aims to improve the design and analysis of disease prevention trials, and observational studies. Recent efforts have brought attention to the profound role that measurement error in assessing individual dietary intakes may play in reducing the reliability of observational studies of food and nutrient consumption and the risk of cancer and other chronic diseases. As a result an innovative research agenda has been advocated thatincludes a major emphasis on international comparisons of dietary habits and cancer incidence rates, the addition of objective biomarkers of nutrient intake to the conduct of cohort and case-control studies, and a major emphasis on dietary intervention development for subsequent testing in controlled intervention trials. Another emphasis has been the development of flexible methods for the analysis of multivariate failure time data. These methods are motivated by the challenges of assessing benefits versus risks in the context of disease prevention trials having multiple clinical outcomes that may be affected by a preventive intervention, and by emerging issues in the identification of cancer related genes and gene-environment interactions.

My applied research, in conjunction with a large group of colleagues and staff members, include coordination of the national Women's Health Initiative. This massive 15 year program randomized over 68,135 postmenopausal women into a clinical trial to evaluate therole of a low-fat eating pattern for the prevention of breast cancer, colorectal cancer and coronary heart disease; to evaluate the role of hormone replacement therapy for the prevention of coronary heart disease and fractures, with breast cancer as a potential adverse outcome; and to evaluate the role of calcium and vitamin D supplementation for the prevention of fractures and colorectal cancer. An additional 93,720 women have been enrolled in an observational study to identify risk factors for this same range of diseases. We operate the clinical coordinating center for this NIH-sponsored program, with clinical, nutritional, epidemiologic, statistical and data management coordination responsibilities. We expect to report the principal findings from the Women's Health Initiative Clinical Trial in 2005-2007.

Keywords

COS Keywords:

Dietary Foods, Disease Prevention, Epidemiology, Nutrition or Dietetics.

Additional Terms:

Dietary Factors and Disease, Disease Prevention Trials, Epidemiologic Methods, Failure Time Analysis.

Memberships

American Association of Preventive Oncology
American Statistical Association
Institute of Medicine
International Biometric Society

Honors and Awards

2005, Award for Research Excellence in Epidemiology and Prevention, American Cancer Society
2005, Marvin Zelen Leadership Award for Outstanding Achievement in Statistical Science, Harvard University
2003, Mantel Award for Lifetime Contributions to Statistics in Epidemiology, American Statitical Association
2002, Alumni Achievement Medal, Faculty of Mathematics, University of Waterloo
1990, Elected Member, Institute of Medicine, National Academy of Sciences
1986, COPSS President's Award, ASA, Biometric Society, IMS and SSC
1982, Fellow, American Statistical Association
1980, Mortimer Spiegelman Award, APHA
1978, Purdue Frederick Award, ACOG

Previous Positions

1980-1981, Biostatistician, Radiation Effects Research Foundation
1974-1977, Associate Professor, University of Washington, School of Public Health and Community Medicine, Biostatistics
1971-1972, Visiting Assistant Professor, University at Buffalo, School of Medicine and Biomedical Sciences, Statistics
1970-1974, Assistant Professor, University of Waterloo, Statistics

Publications

  • Prentice RL, Chlebowski RT, Stefanick ML, Manson JE, Pettinger M, Hendrix SL, Hubbell FA, Kooperberg C, Kuller LH, Lane DS, McTiernan A, O'Sullivan MJ, Rossouw JE, Anderson GL (2008) Estrogen Plus Progestin Therapy and Breast Cancer Among Recently Postmenopausal Women, Am J Epidemiol
  • Prentice RL, Zhong H (2008) Bias-Reduced Estimators and Confidence Intervals for Odds Ratios in Genome-Wide Association Studies, Biostatistics
  • Heiss G, Wallace R, Anderson G, Aragaki A, Brzyski R, Gass M (2008) Health Risks and Benefits 3 Years After Stopping Randomized Treatment with Estrogen and Progestin, JAMA, 299:1036-1045
  • Neuhouser ML, Tinker L, Shaw PA, Schoeller D, Bingham SA, Van Horn L, Beresford SA, Caan B, Thompson C, Satterfield S, Kuller L, Heiss G, Smit E, Sarto G, Ockene J, Stefanick ML, Assad A, Runswick S, Prentice RL (2008) Use of Recovery Biomarkers to Calibrate Nutrient Consumption Self-Reports in the Women's Health Initiative, Am J Epidemiol, 167(10):1247-1259
  • Prentice RL (2008) On the Role of Potential High-Dimensional Biologic Data in Cance Research. To Appear, High-Dimensional Data Analysis in Oncology, Xiachun Li and Ronghui Xu eds.
  • Prentice RL, Chlebowski RT, Stefanick ML, Manson JE, Langer RD, Pettinger M, Hendrix SL, Hubbell FA, Kooperberg C, Kuller LH, Lane DS, McTiernan A, O'Sullivan MJ, Rossouw JE, Anderson GL (2008) Conjugated Equine Estrogens and Breast Cancer Risk in the Women's Health Initiative Clinical Trial and Observational Study, Am J Epidemiol, 167(12):1407-1415
  • Prentice RL (2008) Commentary on 'Breast Tomours Following Combined Hormone Replacement Therapy Express Favourable Prognostic Factors' by Borgquist S et al., Breast Diseases: A Year Book Quarterly, 18:347-348
  • Prentice RL (2008) Women's Health Initiative Studies of Postmenopausal Breast Cancer. In Hormonal Carcinogenesis V. Li JJ, Li SA, Mohla S, Rochefort H, and Maudelonda E, eds., Adv Exp Med and Biol, 617:151-160
  • Pepe MS, Feng Z, Huang Y, Longton G, Prentice R, Thompson IM, Zheng Y (2007) Integrating Predictiveness of a Marker with its Perofrmance as a Classifier, Am J Epidemiol, 167(3):362-368
  • Prentice RL (2007) A Look Foward to the Year 2032, Ann Epidemiol, Epub, 11:906-910
  • Rossouw JE, Prentice RL, LaCroix AZ, Wu L, Manson JE, Barad D, Barnabei VM, Margolis K, Stefanick M (2007) Hormone Therapy and Cardiovascular Risk (Response to Letters), JAMA, 298:624-625
  • Prentice RL, Anderson G (2007) The Women's Health Initiative: Lessons Learned, Ann Rev Public Health, 29:131-150
  • Prentice RL (2007) Observational Studies, Clinical Trials, and the Women's Health Initiative., Lifetime Data Anal, 13:449-462
  • Prentice RL, Thomson CA, Caan B, Hubbell FA, Anderson GL, Beresford SA, Pettinger M, Lane DS, Lessin L, Yasmeen S, Singh B, Khandekar K, Shikany JM, Satterfield S, Chlebowski RT (2007) Low-Fat Dietary Pattern and Cancer Incidence in the Women's Health Initiative Dietary Modification Trial, J Natl Cancer Inst, 99:1534-1543
  • Prentice RL (2007) Discussion of 'Maximum Likelihood Estimation in Semiparametric Regression Models with Censored Data' by D. Zeng and DY Lin, J R Statistics Soc B, 69:555
  • Rossouw JE, Prentice R, Manson JE, Barad D, Barnabei VM, Margolis K, Stefanick M (2007) Hormone Therapy and Cardiovascular Disease (Response to Letters), JAMA, 298:624-625
  • Manson JE, Allison MA, Rossouw JE, Prentice RL (2007) Estrogen Therapy and Coronary Artery Calcification, N Engl J Med, 356:2591-2602
  • Gorfine M, Lipshtat N, Freedman LS, Prentice RL (2007) Linear Measurement Error Models with Restricted Sampling, Biometrics, 63:137-142
  • Sugar EA, Wang CY, Prentice RL (2007) Logistic Regression with Exposure Biomarkers and Flexible Measurement Error, Biometrics, 63:143-151
  • Anderson GL, Kooperberg C, Geller N, Rossouw JE, Pettinger M, Prentice RL (2007) Monitoring and Reporting of the Women's Health Initiative Randomized Hormone Therapy Trials, Clinical Trials, 4:207-217
  • Prentice RL (2007) Statistical Methods and Challenges in Epidemiology and Biomedical Research. Handbook of Statistics: Epidemiology and Medical Statistics, CR Rao, J Miller, and DC Rao, eds. Elsevier, 27:1-27
  • Rossouw JE, Prentice R, Manson JE, Wu L, Barad D, Barnabei VM, Ko M, LaCroix AZ, Margolis KL, Stefanick ML (2007) Postmenopausal Hormone Therapy and Risk of Cardiovascular Disease by Age and Years Since Menopause, JAMA, 297:1465-1477
  • Prentice RL (2007) Clinical Trials and Observational Studies to Assess the Chronic Disease Benefits and Risks of Multivitamin-Multimineral Supplements, Am J Clin Nutr, 85:3085-3135
  • Freedman LS, Potischman N, Kipnis V, Midthune D, Schatzkin A, Thompson FE, Troiano RP, Prentice RL, Patterson RE, Carroll R, Subar AF (2006) A Comparison of Two Dietary Instruments for Evaluating the Fat-Breast Cancer Relationship, Int J Epidemiol, 35(4):1011-21
  • Prentice RL, Stefanick ML, Howard BV, Barad D, Kuller L (2006) Five Authors Reply (Reponse to Letter), Am J Epidemiol, 163
  • Prentice RL, Caan B, Chlebowski RT, Aragaki A, Patterson RE (2006) Low-Fat Diet and Breast Cancer (Response to Letters), JAMA, 296:229
  • Prentice RL, Qi L (2006) Aspects of the Design and Analysis of High-Dimensional SNP Studies for Disease Risk Estimation, Biostatistics, 7:339-354
  • Prentice RL, Langer R, Stefanick ML, Howard BV, Pettinger M, Anderson G, Barad D, Curb JD, Kotchen J, Kuller L, Wactawksi-Wende J (2006) For the Women's Health Initiative Investigators. Combined Analysis of Women's Health Initiative Observational and Clinical Trial Data on Postmenopausal Hormone Treatment and Cardiovascular Disease, Am J Epidemiol, 163:589-599
  • Curb D, Prentice R, Bray P, Langer RD, Van Horn L, Barnabei VM, Black M, Cyr M, Gass M, Lepine L, Mattox J, Rodabough R, Sidney S, Uwaifo GI, Rosendaal FR (2006) Hormone Therapy and Risk of Venous Thrombosis in the Women's Health Initiative Trial of Conjugated Equine Estrogen in Women without a Uterus, Arch Intern Med, 166:7720780
  • Jackson RD, LaCroix AZ, Gass M, Prentice RL (2006) Calcium Plus Vitamin D Supplementation and the Risk of Fractures, N Engl J Med, 354:669-683
  • Wactawski-Wende K, Kotchen JM, Anderson GL, Prentice RL (2006) Calcium Plus Vitamin D Supplementation and the Risk of Colorectal Cancer, N Engl J Med, 354:684-696
  • Beresford SAA, Johnson KC, Ritenbaugh C, Prentice RL (2006) Low-Fat Dietary Pattern and Risk of Colorectal Cancer: The Women's Health Initiative Randomized Controlled Dietary Modification Trial, JAMA, 295:643-654
  • Howard BV, Van Horn L, Hsia J (2006) Low-Fat Dietary Pattern and Risk of Cardiovascular Disease: The Women's Health Initiative Randomized Controlled Dietary Modification Trial, JAMA, 295:655-666
  • Prentice RL, Caan B, Chlebowski RT (2006) Low-Fat Dietary Pattern and Risk of Invasive Breast Cancer: The Women's Health Initiative Randomized Controlled Dietary Modification Trial, JAMA, 295:629-642
  • Howard BV, Manson JE, Stefanick ML, Beresford SAA, Frank G, Jones B, Rodabough RJ, Snetselaar L, Thomson C, Tinker L, Vitolins M, Prentice RL (2006) Low-Fat Eating Pattern and Weight Change Over 7 Years - The Women's Health Initiative Dietary Modification Trial, JAMA, 295:39-49
  • Hsia J, Langer RD, Manson JE, Kuller LH, Johnson KC, Hendrix S, Pettinger M, Heckbert SR, Greep N, Crawford S, Eaton CB, Kostis JB, Caralis P, Prentice RL (2006) For the Women's Health Initiative. Conjugated Equine Estrogens and the Risk of Coronary Heart Disease, Arch Intern Med, 166:357-365
  • Prentice RL (2005) Observational Studies and Intervention Trials in Exercise, Diet, and Cancer Prevention Research. Cancer Prevention Management through Exercise and Weight Control. McTiernan A, editor., Marcel Dekker Inc., pp. 1-11
  • Prentice RL, Langer R, Anderson GL, Barad D (2005) Response to Commentary, 'How Far Can Epidemiologists Get with Statistical Adjustment' by Diana Pettiti, Am J Epidemiol, 162:419-420
  • Prentice RL, Pettinger M, Anderson GL (2005) Statistical Issues Arising in the Women's Health Initiative (with Discussion), Biometrics, 61:899-941
  • Moodie FZ, Prentice RL (2005) An Adjustment to Improve the Bivariate Survivor Function Repaired NPMLE, Lifetime Data Anal, 11:291-307
  • Prentice RL, Langer R, Stefanick M, Howard B, Pettinger M, Anderson G, Barad D, Curb D, Kotchen J, Kuller L, Limacher M, Wactawski-Wende J (2005) For the Women's Health Initiative Investigators. Combined Postmenopausal Hormone Therapy and Cardiovascular Disease: Toward Resolving Discrepancy Between Women's Health Initiative Clinical Trial and Observational Study Results, Am J Epidemiol, 162:404-414
  • Stefanick ML, Prentice RL, Anderson GL, Gass M, Manson JE (2005) Reanalysis of WHI Oral Contraceptive Data Reveals No Evidence of Delayed Cardiovascular Benefit, Fertil Steril, 83:853-854
  • Qi L, Wang CY, Patterson RE (2005) Weighted Estimators for Proportional Hazards Regression with Missing Covariates, J Am Stat Assoc, 100:1250-1263
  • Prentice RL (2005) Cohort Studies, Encyclopedia of Statistics in Behavioral Science, 2nd Edition, Everitt B, Howell D (eds), pp. 322-326
  • Yang S, Prentice R (2005) Semiparametric Analysis of Short Term and Long Term Relative Risks with Two Sample Survival Data, Biometrika, 92:1-17
  • Prentice RL (2005) Developed under the Auspices of the UNESCO, EOLSS Publishers, Oxford, UK, Nutritional Epidemiology, in Modern Biometry, in Encyclopedia of Life Support Systems (EOLSS), http://www.eolss.net
  • Prentice RL, Anderson G (2005) Women's Health Initiative - Statistics Aspects and Early Results, Encyclopedia of Biostatistics, Second Edition, Armitage P, Colton T (eds.)
  • Prentice RL (2005) Surrogate Endpoint Definition and Evaluation. In "The Evaluation of Surrogate Endpoints", Burzykowski T , Molenberghs G, Buyse M (eds.), Springer Publishing Company, New York, pp. 341-348
  • Prentice RL (2005) Measurement Error in Survival Analysis, Encyclopedia of Biostatistics, Second Edition, V5, pp.3095-3100, Wiley, Chichester
  • Cushman M, Prentice R, Psaty B, Rosendaal FR (2005) Response to Letters to the Editor on 'Hormone Therapy and Risk of Venous Thrombosis in the WHI Trial of Estrogen Plus Progestin', JAMA, 293:1322-1323
  • Chlebowski RT, Chen Z, Anderson GL, Rohan T, Aragaki, Lane D, Dolan N, Paskett ED, McTiernan A, Hubbell FA, Adams-Campbell L, Prentice RL (2005) Ethnicity and Breast Cancer: Factors Influencing Differences in Incidence and Outcome, JNCI, 97(6):439-448
  • Prentice RL (2005) Ethics and Sample Size - Anothe View, Am J Epidemiol, 161(2):111-112
  • Margolis K, Manson J, Greenland P, Rodabough R, Bray P, Safford M, Grimm R, Howard B, Assaf A, Prentice R (2005) Leukocyte Count as a Predictor of Cardiovascular Events and Mortality in Postmenopausal Women, Arch Intern Med, 165:1-9
  • Prentice RL, Moodie Z, Wu J (2004) Nonparametric Estimation of the Bivariate Survivor Function. Proceedings of the Second Seattle Symposium in Biostatistics, Analysis of Correlated Data, Lecture Notes in Statistics, Vol 179, Springer-Verlag, VII, pp. 113-142
  • Cushman M, Kuller LH, Prentice RL, Sidney S, Stafford RS, Psaty BM, Rodabough R, Rosendaal FR (2004) Hormone Therapy Risk of Venous Thrombosis in the Women's Health Initiative Trial of Estrogen Plus Progestin, JAMA, 292:1573-1580
  • Feng Z, Prentice RL, Srivastava S (2004) Research Issues and Strategies for Genomic and Proteomic Biomarkers Discovery and Validation: A Statistical Perspective, Pharmacogenetics, 5(6):709-719
  • Prentice RL, Willett WC, Greenwald P, Alberts D, Bernstein L, Boyd NF, Byers T, Clinton SK, Fraser G, Freedman L, Hunter D, Kipnis V, Kolonel LK, Kristal A, Kristal BS, Lampe J, McTiernan A, Milner J, Patterson R, Potter J, Riboli E, Schatzkin A, Yates A, Yetley E (2004) Nutrition, Physical Activity and Chronic Disease Prevention: Research Strategies and Recommendations, JNCI, 96:1276-1287
  • Prentice RL (2004) Chronic Disease Prevention: Public Health Potential and Research Needs, Stat Med, 23:4309-3420
  • Prentice RL (2004) Postmenopausal Hormone Therapy in Relation to Cardiovascular Disease and Cognition, In Menopause and Hormone Replacement, Critcheley H, Gebbie A, and Beral V (eds), pp.57-65
  • Prentice RL (2004) Effects of Conjugated Equine Estrogens in Postmenopausal Women with Hysterectomy: The Women's Health Initiative Randomized Controlled Trial, JAMA, 291:1701-1712
  • Prentice RL, Moodie Z, Wu J (2004) Hazard-Based Nonparametric Estimation of the Bivariate Survivor Function, JRSS B, 66:305-319
  • Gorfine M, Hsu L, Prentice RL (2004) Nonparametric Correction for Covariate Measurement Error in a Stratified Cox Model, Biostatistics, 5:75-87
  • Brooks DJ, Frey KA, Marek KL, Oakes D, Paty D, Prentice RL, Shults CW, Stoesel AJ (2003) Assessment of Neuroimaging Techniques as Biomarkers of the Progression of Parkinson's Disease, Exp Neurol, 184(Suppl 1):68-79
  • Prentice RL (2003) Dietary Assessment and the Reliability of Nutritional Epidemiology Reports, Lancet, 362:182-183
  • Hendrix SL, Prentice RL (2003) WHI Respone to Goodman, Goldheizer and Ayala's Critique of the Women's Health Initiative Report on the Risks and Benefits of Estrogen Plus Progestin, Menopausal Medicine, 11:1-4, 2003
  • Prentice RL, Kalbfleisch JD (2003) Aspects of the Analysis of Multivariate Failure Time Data, Statistics and Operations Research Transactions, 1:65-78
  • Gorfine M, Hsu L, Prentice RL (2003) Estimation Dependence Between Paired Correlated Failure Times in the Presence of Covariate Measurement Area, JRSS B, 65:643-661
  • Prentice RL, Kalbfleisch JD (2003) Mixed Discrete and Continuous Cox Regression Model, Lifetime Data Anal, 9:195-210
  • Cochrane B, Lund B, Anderson S, Prentice RL (2003) The Women's Health Initiative: Aspects of Management and Coordination, Diversity in Health Care Research: Strategies for Multisite Multidisciplinary and Multiethnic Projects, Hawkins JW and Haggery LA (eds.) Spring Publishing Company, New York, pp.181-207.
  • Anderson G, Manson J, Wallace R, Lund B, Hall D, Davis S, Shumaker S, Wang CY, Stein E, Prentice RL (2003) Implementation of the Women's Health Initiative Study Design, Ann Epidemiol, 13(95):5-17
  • Kalbfleisch JD, Prentice RL (2002) The Statistical Analysis of Failure Time Data, Second Edition, Wiley Series in Probability and Statistics, 439 pages. pages
  • Prentice RL, Sugar E, Wang CY, Neuhouser ML, Patterson RE (2002) Research Strategies and the Use of Biomarkers in Studies of Diet and Chronic Disease, Public Health Nutr, 5"977-984
  • Horner NK, Patterson RE, Neuhouser ML, Lampe JW, Beresford SA, Prentice RL (2002) Participant Characteristics Associated with Errors in Self-Reported Energy Intake from the Women's Health Initiative Food Frequency Questionnaire, Am J Clin Nutr, 76:766-733
  • Fan JJ, Prentice RL (2002) Covariate-Adjusted Dependence Estimation on a Finite Bivariate Failure Time Region, Statistica Sinica, 12:689-705
  • Rossouw JE, Anderson G, Prentice RL (2002) Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women, JAMA, 288:321-333
  • Hsu L, Prentice RL, Stanford JL (2002) Some Further Results in Incorporating Risk Factor Information in Assessing the Dependence Between Paired Failure Times Arising from Case-Control Family Studies: An Application to Prostate Cancer, Stat Med, 21:863-876
  • Hsu L, Prentice RL, Zhao LP, Li S (2001) Incorporating Age at Onset Information into the Transmission-Disequilibrium Test, Genet Epidemiol, 21:347-352
  • Prentice RL, Kalbfleisch JD (2001) Survival Analysis: Overview, International Encyclopedia of Social and Behavioral Sciences, 22:15318-15325
  • Horner NK, Lampe JW, Patterson RE, Neuhouser ML, Beresford SA, Prentice RL (2001) Indirect Calorimetry Protocol Development in Free-Living Postmenopausal Women, J Nutr, 131:2215-2218
  • De Gruttola VG, Clax P, DeMets D, Downing GJ, Ellenberg SS, Friedman L, Gail MH, Prentice RL, Wittes J, Zeger SL (2001) Considerations in the Evaluation of Surrogate Endpoints in Clinical Trials: Summary of a National Institutes of Health Workshop, Control Clin Trials, 22:485-502
  • Prentice RL (2001) A Risk Set Calibration Method for Failure Time Regression Using a Covariate Reliability Sample, JRSS B, 63:855-870
  • Prentice RL, Xie S, Wang CY (2001) Recalibration Based on an Approximate Relative Risk Estimator in Cox Regression with Missing Covariates, Statistica Sinica, 11:1081-1104
  • Prentice RL (2001) Opportunities and Challenges in Chronic Disease Population Research, Biostatistics, 2:365 381
  • Breeden L, Prentice RL, Zhao LP (2001) Statistical Modeling of Large Microarray Datasets to Identify Stimulus-Response Profiles, Proceedings of the National Academy of Sciences, 98:5631-5636
  • Fan JJ, Prentice RL, and Hsu L, A class of weighted dependence measures for bivariate failure time data, Journal of the Royal Statistical Society B, 62, 181-190, 2000
  • Prentice RL, Future possibilities in the prevention of breast cancer. Fat and fiber and breast cancer research, Breast Cancer Research, 2, 268-276, 2000
  • Prentice RL, Opportunities and challenges in chronic disease population research, In press, Biostatistics, 2000
  • 205. Fan JJ, Hsu L, Prentice RL, Dependence estimation over a finite bivariate failure time region, Life Time Data Analysis, 6, 343-355, 2000
  • R. Prentice (2000) Dietary Reference Intakes for Vitamin C, E, Selenium and Carotenoids, Institute of Medicine, National Academy Press, (506 Pages)
  • Yang S and Prentice RL, Semiparametric inference in the proportional odds model, Journal of the American Statistical Association, 94, 125-136, 1999
  • Prentice RL, On nonparametric estimation of the bivariate survivor function, Statistics in Medicine, 18, 2517-2527, 1999
  • Zhao LP, Prentice RL, Shen F, and Hsu L, On the assessment of statistical significance in disease gene discovery, American Journal of Human Genetics, 64, 1739-1753, 1999
  • Hsu L, Prentice RL, Zhao LP, and Fan JJ, On dependence estimation using correlated failure time data from case-control family studies, Biometrika, 86, 743-754, 1999
  • Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group, Controlled Clinical Trials, 19(1), 61-109, February 1998 Abstract
  • Anderson AB and Prentice RL, On the use of a spatial modelling technique for relative risk estimation in aggregate data studies of disease risk factors, Biometrics, 54, 1527-1540, 1998
  • Zhao LP, Hsu L, Holte S, Chen Y, Quiaoit F, and Prentice RL, Combined association and aggregation analysis of case-control family studies, Biometrika, 85, 299-315, 1998
  • Prentice RL, and Hsu L, Regression on hazard ratios and cross ratios in multivariate failure time analysis, Biometrika, 84(2), 349-363, 1997
  • Wang CY, Hsu L, Feng ZD, and Prentice RL, Regression calibration in failure time regression with surrogate variables, Biometrics, 53, 131-145, 1997
  • Prentice RL, Measurement error and results from analytic epidemiology: dietary fat and breast cancer [see comments], JNCI, 88(23), 1738-47, December 1996 Abstract
  • Hsu L, and Prentice RL, On assessing the strength of dependence between failure time variates, Biometrika, 83, 491-506, 1996
  • Hsu L, and Prentice RL, A generalization of the Mantel-Haenszel test to bivariate failure time data, Biometrika, 83(4), 905-911, 1996
  • Sheppard L, Prentice RL and Rossing MA, Design considerations for estimation of exposure effects on disease risk, using aggregate data studies, Stat Med, 15, 1849-1858, 1996
  • Prentice RL, On the role, design, and analysis of disease prevention trials, Controlled Clinical Trials, 16(4), 249-58, August 1995 Abstract
  • Prentice RL, Experimental methods in cancer prevention research, In Cancer Prevention and Control, P Greenwald, B Kramer and DL Weed (eds.), Marcel Dekker, New Y, 213-224, 1995
  • Prentice RL and Sheppard L, Aggregate data studies of disease risk factors, Biometrika, 82, 113-125, 1995
  • Cai J and Prentice RL, Estimating equations for multivariate failure time regression, Biometrika, 151-164, 1995
  • Sheppard L, Prentice RL, On the reliability and precision of within- and between-population estimates of relative risk parameters, Biometrics, 853-863, 1995
  • Fleming TR, Prentice RL, Pepe MS, Glidden D, Surrogate and auxiliary endpoints in clinical trials, with potential applications in cancer and AIDS research., Stat Med, 13(9), 955-68, 15 1994 Abstract
  • Fleming TR, Prentice RL, Pepe M and Glidden D, Surrogate and auxiliary endpoints in clinical trials, with potential applications in cancer and AIDS research, Stat Medicine, 13, 955-968, 1994
  • Prentice RL, Thomas DC, Methodologic research needs in environmental epidemiology: Data analysis, Environmental Health Persp 101, (Suppl 4), 39-48, 1993
  • Prentice RL, Thomas DC, Methodologic research needs in environmental epidemiology: Data analysis, Environmental Health Persp 101, (Suppl 4), 39-48, 1993
  • Prentice RL, Smythe RT, Krewski D, Mason M, On the use of historical control data to estimate dose response trends in quantal bioassay, Biometrics, 48(2), 459-78, June 1992 Abstract
  • Prentice RL, Cai J, Covariance and survivor function estimation using censored multivariate failure time data, Biometrika, 79, 495-512, 1992
  • Zhao LP, Prentice RL, Self SG, Multivariate mean parameter estimation using a partly exponential model, Journal of the Royal Statistical Society B, 54, 805-811, 1992
  • Prentice RL, Zhao LP, Estimating equations for parameters in means and covariances of multivariate discrete and continuous responses, Biometrics, 47(3), 825-39, September 1991 Abstract
  • O'Quigley J, Prentice RL, Nonparametric tests of association between survival time and continuously measured covariates; the logit-rank and associated procedures, Biometrics, 47, 117-127, 1991
  • Prentice RL, Sheppard L, Dietary fat and cancer: rejoinder and discussion of research strategies, Cancer Causes and Control, 2(1), 53-8, January 1991 Abstract
  • Prentice RL, Sheppard L, Dietary fat and cancer: consistency of the epidemiologic data, and disease prevention that may follow from a practical reduction in fat consumption [published erratum appears in Cancer Causes Control, Cancer Causes and Control, 1(1), 81-97, July 1990 Abstract
  • Prentice RL, Thompson DJ, Clifford C, Gorbach S, Goldin B, Byar D, Dietary fat and reduction and plasma estradiol concentration among healthy postmenopausal women, JNCI, 82, 129-134, 1990
  • Prentice RL, Tamoxifen as a potential preventive agent among healthy postmenopausal women, JNCI, 82, 1310-1311, 1990
  • Zhao LP, Prentice RL, Correlated binary regression using a quadratic exponential model, Biometrics, 77, 642-648, 1990
  • Prentice RL, Opportunities for enhancing efficiency and reducing cost in large scale disease prevention trials: a statistical perspective, Stat Med, 9(1-2), 161-70, 1990 Abstract
  • Prentice RL, Thomas DB, Epidemiology of oral contraceptives and disease, Advances in Cancer Research, 49, 285-401, 1987
  • Moolgavkar SH, Prentice RL, Modern Statistical Methods in Chronic Disease Epidemiology, Wiley, New York, 282 pages, 1986
  • Kalbfleisch JD, Prentice RL, The Statistical Analysis of Failure Time Data, Wiley Series in Probability and Statistics, April 1980, 321 pages, 1980

Profile Details

Last Updated: 8/8/2008

COS Expertise ID #373800
Reference this profile directly: http://myprofile.cos.com/prenticr00